Form 4: Bioventus Inc. Executive Sells Shares to Cover Taxes After Stock Vesting

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 3,054 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Summary

• On April 11, 2024, Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 3,054 shares of Class A Common Stock.
• The shares were sold at a weighted average price of $4.75.
• The sale was executed to cover taxes upon the vesting of restricted stock units on April 10, 2024, pursuant to a pre-arranged 10b5-1 trading plan adopted on April 10, 2023.
• Following the transaction, D'Adamio beneficially owns 58,242 shares of Bioventus Inc. Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (stock sale for tax purposes) and does not contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations after vesting are a common practice among corporate executives and are generally viewed as routine transactions.

Comparison to Industry Standards

• Executive stock sales for tax purposes are a standard practice across publicly traded companies.
• The use of 10b5-1 trading plans is a common method to avoid accusations of insider trading, aligning with industry best practices.
• Comparable companies such as Stryker, Zimmer Biomet, and Medtronic also see similar transactions from their executives.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates